GlassScriptPhysician profile
Caitlin E Idaspe
NPI 1376095190
$1,829.50
in general payments reported to CMS, 2019-2025
27 companies · $795 in 2025
The $795 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $368 · 2022: $398 · 2023: $124 · 2024: $145 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $367.79 | 2021-2025 | Rybrevant, Carvykti, Erleada |
| Abbvie INC. | $183.79 | 2022-2025 | |
| Boston Scientific Corporation | $119.74 | 2025 | Spaceoar System, Axonics |
| Astellas Pharma US INC | $99.53 | 2021 | |
| Axonics, INC. | $91.48 | 2023-2024 | Axonics, Bulkamid |
| Blue Earth Diagnostics | $90.77 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $89.54 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $88.93 | 2025 | |
| Coloplast Corp | $79.77 | 2022-2025 | Titan |
| Allergan, INC. | $77.56 | 2021-2022 | |
| Immunitybio, INC. | $57.89 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $54.23 | 2022-2023 | Seglentis |
| Alnylam Pharmaceuticals INC. | $49.50 | 2022 | |
| Antares Pharma, INC. | $47.92 | 2022 | |
| Biocomposites INC | $35.28 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $32.73 | 2025 | Barrigel |
| Endo Pharmaceuticals INC. | $32.54 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $31.75 | 2021 | |
| Abc Home Medical Supply, INC. | $28.08 | 2025 | |
| Dendreon Pharmaceuticals LLC | $26.57 | 2025 | Provenge |
| Davol INC. | $25.26 | 2025 | Arista |
| Tolmar Pharmaceuticals, INC. | $23.97 | 2022 | |
| Dentsply Ih Ab | $22.57 | 2025 | Lofric |
| Bluewind Medical | $21.61 | 2025 | |
| Urovant Sciences INC | $20.70 | 2022 | |
| Endo USA, INC. | $16.82 | 2025 | Aveed, Xiaflex |
| Mission Pharmacal Company | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Idaspe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.